FIELD: medicine.
SUBSTANCE: method for preeclampsia diagnosis in pregnant women with chronic kidney disease (CKD) includes determination of a soluble fms-like tyrosine kinase and placental growth factor are determined in pregnant woman's blood, the ratio of the first value to the second is calculated, and at the ratio greater than 20 in the second trimester of pregnancy and at the ratio greater than 65 in the third trimester of pregnancy, preeclampsia is diagnosed.
EFFECT: method allows to diagnose the disease, start timely monitoring of preeclampsia signs, treatment and timely preparation for delivery.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF ISOLATED PREECLAMPSIA AND PREECLAMPSIA, DEVELOPING ON THE BACKGROUND OF UNDIAGNOSED CHRONIC ARTERIAL HYPERTENSION | 2019 |
|
RU2713436C1 |
| METHOD OF PROLONGING PREGNANCY IN EARLY PRE-ECLAMPSIA | 2023 |
|
RU2803574C1 |
| METHOD FOR PREDICTING EFFECTIVENESS OF TREATMENT OF MODERATE PREECLAMPSIA | 2020 |
|
RU2752715C1 |
| METHOD FOR FORMING RISK GROUP OF PRE-ECLAMPSIA | 2021 |
|
RU2762204C1 |
| METHOD FOR FETOPLACENTAL INSUFFICIENCY PREVENTION FOR PREGNANT WOMEN WITH CHRONIC KIDNEY DISEASE | 2016 |
|
RU2623064C1 |
| METHOD FOR CHOOSING MANAGEMENT APPROACH TO PREGNANT WOMEN WITH MODERATE PREECLAMPSIA | 2011 |
|
RU2477481C1 |
| METHOD FOR FORECASTING SEVERITY OF EARLY PREECLAMPSY | 2021 |
|
RU2753463C1 |
| METHOD FOR PREDICTING ADVERSE PREGNANCY OUTCOMES IN WOMEN WITH TYPE 1 DIABETES MELLITUS IN THE SECOND HALF OF PREGNANCY | 2020 |
|
RU2759076C1 |
| METHOD OF DIAGNOSTICS OF SEVERITY OF PRE-ECLAMPSIA ON THE BACKGROUND OF CHRONIC ARTERIAL HYPERTENSION IN PREGNANT WOMEN | 2023 |
|
RU2804645C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPMENT OF PRE-ECLAMPSIA IN WOMEN OF DIFFERENT SOMATOTYPES | 2018 |
|
RU2679111C1 |
